| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4461c6d3a27f3ca8f2d61728a9ee65bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
| filingDate |
2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743310e7d524d92f737d9c6a1ff7829e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c886feeed57313c64ec4fe93ca361427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ca1c3ad5ffe2645056f6b081e0f125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aff322eebbfc23858bb281f18433289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291835a457c07d9db541685efab6aeaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a392464bc772f355cd40e5d537bb314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7b9d433fe9566d365dfe71b993d47c7 |
| publicationDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020068687-A1 |
| titleOfInvention |
Compositions and methods for the in situ delivery of therapeutic and diagnostic agents |
| abstract |
Synthetic minimal cells (SMC) are provided for delivering a therapeutic or diagnostic agent to a subject or to a site within a subject in need of treatment or diagnosis. SMCs may be targeted to the site or sense the site and initiate production and release of the therapeutic or diagnostic agent. SMCs comprise a sensor, at least one genetic circuit and outputting means to deliver the therapeutic agent. |
| priorityDate |
2018-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |